Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 810 results for "ast"

Can a group of runners really outpace the T?

L ast Sunday, members of the Michael Scott Road Runners did what they typically do the second or third weekend of every month: They gathered at a local T station, did their best to shake off any lingering hangovers, and set out to race an MBTA Green ... Boston.com, 1 day ago
CBC

Asterias Biotherapeutics Inc. (AST) Rating Lowered to Hold at Zacks Investment Research

Zacks Investment Research lowered shares of Asterias Biotherapeutics Inc. (NYSEMKT:AST) from a buy rating to a hold rating in a report released on Monday. According to Zacks, Asterias Biotherapeutics, Inc. is a biotechnology company. It is ...
 Zolmax News2 days ago Regina businessman Wayne Ast running for mayor  CBC4 days ago Asterias Biotherapeutics (AST) Buy Rating Reiterated at FBR & Co  Mideast Time5 days ago Zacks Investment Research Downgrades Asterias Biotherapeutics Inc. (AST) to Hold  American Banking News5 days ago
[x]  

AST Groupe FY revenue up 22 pct to 61.1 million euros

Eikon Information, analytics and exclusive news on financial markets - delivered in an intuitive desktop and mobile interface Elektron Everything you need to empower your workflow and enhance your enterprise data management ...
 Reuters UK3 days ago

Injured Southee ruled out of Test series

ast bowler Tim Southee has been ruled out of the three-match Test series in India after he suffered an ankle injury during training. Southee felt pain in his front foot while bowling in training, with a scan showing a grade two ligament strain in ...
 New Delhi Pioneer1 week ago
Nasdaq

Why Asterias Biotherapeutics (AST) Could Be Positioned for a Surge?

Asterias Biotherapeutics, Inc. AST is a biotechnology company that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate ...
 Nasdaq4 days ago Asterias Bio reports encouraging interim results in early-stage study of AST-OPC1 cells in spinal cord injury; shares up 6%  Seeking Alpha1 week ago
[x]  

Astur Gold hires HSF for Salave permitting

2016-09-19 11:18 ET - Shareholders Letter Mr. Brian Wesson reports ASTUR GOLD SEPTEMBER 2016 LETTER TO SHAREHOLDERS Astur Gold Corp.'s president and chief executive officer, Brian Wesson, has released the following letter on behalf of the ...
 Stockwatch6 days ago Astur Gold September 2016 Letter to Shareholders  Digital Journal6 days ago ASTUR GOLD : September 2016 Letter to Shareholders  4 Traders6 days ago
[x]  
Zacks.com

Asterias Biotherapeutics (AST) Catches Eye: Stock Jumps 6%

Asterias Biotherapeutics, Inc. AST was a big mover last session, as the company saw its shares rise 6% on the day. Shared gained after the company resented positive interim efficacy data from the 10 million cell cohort of the AST-OPC1 SCiSTAR phase ...
 Yahoo! Singapore1 week ago Asterias Biotherapeutics (AST) Soars: Stock Rises by 10.9%  Yahoo! Singapore1 week ago
[x]  

Elsevier and National Academy of Sciences Recognize Achievement of India's Young Scientists at 10-Year Anniversary Celebration

/PRNewswire/ -- Nine W inners of the 2016 NASI-Scopus Young Scientist Awards J oin 82 P ast R ecipients in the A wards ' R oll of H onor Elsevier , a world-leading provider of scientific, technical and medical information products ...
 Yahoo! Finance1 week ago
[x]  
BioSpace

Asterias Biotherapeutics AST-OPC1 Treatment for Spinal Cord Injury Patients Shown to Help Patients Paralyzed from the Neck Down Regain Function in the Arms and Hands

FREMONT, Calif. , Sept. 14, 2016 /PRNewswire/ -- The News: Asterias Biotherapeutics, based in Fremont, California , announced today positive interim efficacy data in the Company's ongoing Phase 1/2a clinical study in complete cervical spinal ...
 BioSpace1 week ago
[x]  
Nasdaq

Will Asterias Biotherapeutics (AST) Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor in Asterias Biotherapeutics, Inc. AST . The stock has moved higher by 27.2% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance ...
 Nasdaq1 week ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - ast
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less